Member Info for Kjn2

Kendall - show us your max SLB rental overage and price that can be paid under that fcf support. Everyone eager because you haven’t mentioned a single numeric fact just random statements.

I would add the company has had a few takeover situations already and at some point the market and potential buyers don’t take the Board and main holders seriously imo.

You can’t run an M&A process every 2-3 years. Potential buyers don’t want to spend money on any process that doesn’t have serious sellers and realistic sale price expectations.

That’s why imo the share price is beyond depressed atm.

Rates obviously play a role, but don’t forget main holders outside of Mediclinic are investors. They look at their current IRR and all of them are underwater pretty much after 3-8 years. So they look at it on an annualized basis. 300 doesn’t work for sponsors. So has to be a strategic with little presence in the UK. No one will pay full value. Maybe a strategic will pay 270.

“Laura” said 300+ even.

By now the Board should update, has been more than half a year. Either there is traction and they negotiate or they present their alternative deal structure. They should finally be held accountable by the owners imo. Even if it’s an opco structure, this should have been presented by now.

3£ doesn’t work for financial sponsor returns. Sell side has extensively written about it. Think they said around max 270 work.

Strategics left. Some have antitrust hurdles. So overseas without presence best.

Briarwood Chase Management increased their stake further.

No, Spire can reach out to 100 parties. Unless all formally stated that they are out and the company hasn’t reached out to more potential buyers the review isn’t done. Speak to some counsels to learn.

Metage Capital also reported an 8.3. Another one with the US hedge fund that disclosed.

Incorrect, clown Kendall. Like all your other useless posts.

The company can keep the review open as long as they want. You should speak to a counsel on UK takeover law. But you probably don’t understand what that means.

This can be a hedge, so standalone meaningless.

No, there isn’t an end to the process unless Spire decide to conclude it.

Unless Sky or whoever leaks another bidder, that would trigger another Pusu.

Not sure what’s more idiotic, your comments or your user name. Just sell you 250 shares and give everyone here a break.

There is other articles out there, let us know once you have found the Google button.

Kendall: you are the dumbest user this forum has seen. You can’t google, none of your posts have added any useful information. Can’t google a simple fact, you clown:

https://healthinvestor.co.uk/exclusive-mediclinic-looking-to-divest-from-spire/#:~:text=Exclusive:%20Mediclinic%20looking%20to%20divest,M&A

Who sold? Or buying free float.

A 5% holder can’t force a sale. It was reported Mediclinic want to sell. And Tosca is a financial investor so go figure.

Why don’t you add value at least in one post and stop responding with completely irrelevant posts.

It was said fees for the sale process are 7m, that was excluding the last couple weeks.

EV is around 1bn incl net debt. Usually for small caps the fees are 70-100bps for a successful sale to M&A advisers only. That would be 7-10m.

So what happened? No sale yet but spent already that much of a successful sale. Is there any corporate governance prevailing at Spire?

If I had to guess it wasn’t only Harwood initiating the sale process but also Tosca and Mediclinic. Latter one can block any scheme of arrangement.

The Board answers to shareholders, not the other way around. You misunderstood that important part.

Foreign buyers / SWFs sound reasonable. If not, could imagine whole board including CEO get dismissed.

I also believe we may hear news soon. The large holders can’t be happy that Rothschild get paid a small fortune while the review has delivered nothing but massive losses to shareholders.

Either the board and ceo get let go at the GM or a deal happens imo.

Mediclinic and Tosca must be fuming how the process has been handled I guess.